Others Also Read

Pfizer introduces two novel therapies to treat patients across the atopic dermatitis disease spectrum

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia.